Uric Acid and the Kidneys: A Role for Urate Lowering?

April 2013
Renal & Urology News;Apr2013, Vol. 12 Issue 4, p14
The article discusses several studies which suggest that uric acid increases vascular risk in people. It cites a study which demonstrates that higher uric acid levels were associated with an increased risk of cardiovascular diseases (CVD) events. Another study shows that allopurinol used for lowering uric acid levels was associated with better blood pressure control. It suggests the importance of defining the relationship among uric acid, kidney disease, and CVD.


Related Articles

  • Long-Term Inhibition of Xanthine Oxidase by Febuxostat Does Not Decrease Blood Pressure in Deoxycorticosterone Acetate (DOCA)-Salt Hypertensive Rats. Szasz, Theodora; Davis, Robert Patrick; Garver, Hannah S.; Burnett, Robert J.; Fink, Gregory D.; Watts, Stephanie W. // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Xanthine oxidase and its products, uric acid and ROS, have been implicated in the pathogenesis of cardiovascular disease, such as hypertension. We have previously reported that allopurinol inhibition of XO does not alter the progression of deoxycorticosterone acetate (DOCA)-salt hypertension in...

  • Antihypertensive activity and renal effects of benazepril in humans. Tramonti, Gianfranco; Donadio, Carlo; Confessore, Nicola; Bianchi, Claudlo // Kidney International;Jun1996 Supplement, Vol. 49, pS107 

    The effects of the treatment with benazepril (BEN) on blood pressure and renal function have been evaluated in nine adult patients affected by mild to moderate hypertension. BEN was administered orally, at a single daily dose of 10 mg for four weeks. BEN induced a clinically significant decrease...

  • Aggravation of Immunoglobulin A Nephropathy by Hyperuricemia A Mini-Review on Current Findings and New Concepts. Nasri, Hamid; Baradaran, Azar // Iranian Journal of Kidney Diseases;Sep2014, Vol. 8 Issue 5, p359 

    Immunoglobulin A (IgA) nephropathy (IgAN) is the most common form of primary glomerulopathy worldwide. Various investigations have addressed the clinical and morphological risk factors related to the risk of progression. Recently, much attention has been made toward the prognostic implication of...

  • A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Praveen, Devarsetty; Patel, Anushka; McMahon, Stephen; Prabhakaran, Dorairaj; Clifford, Gari D.; Maulik, Pallab K.; Joshi, Rohina; Jan, Stephen; Heritier, Stephane; Peiris, David // Implementation Science;2013, Vol. 8 Issue 1, p1 

    Background Blood Pressure related disease affected 118 million people in India in the year 2000; this figure will double by 2025. Around one in four adults in rural India have hypertension, and of those, only a minority are accessing appropriate care. Health systems in India face substantial...

  • Continental-Mediterranean and rural-urban differences in cardiovascular risk factors in Croatian population. Bergman Marković, Biserka; Vrdoljak, Davorka; Kranjčević, Ksenija; Vučak, Jasna; Kern, Josipa; Bielen, Ivan; Ivezić Lalić, Dragica; Katić, Milica; Reiner, Željko // Croatian Medical Journal;Aug2011, Vol. 52 Issue 4, p566 

    Aim To compare the distribution of cardiovascular disease (CVD) factors between continental and Mediterranean areas and urban and rural areas of Croatia, as well as to investigate the differences in achieving treatment goals by the general practitioners (GP) in different settings. Methods A...

  • Uric Acid and CV Risk: Not Ready Yet.  // OB/GYN Clinical Alert;Jan2009 Clinical Briefs in Primary, p2 

    The article reports on the findings of the study, which examined the relationship between uric acid (URA) and cardiovascular risk (CV). This study found that the association between URA and CV is not independent of hypertension, making it disqualified from being an independent risk factor. It...

  • Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Feig, Daniel I.; Nakagawa, Takahiko; Karumanchi, S. Ananth; Oliver, William J.; Duk-Hee Kang; Finch, Jennifer; Johnson, Richard J. // Kidney International;Jul2004, Vol. 66 Issue 1, p281 

    Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Background. Essential hypertension affects more than 25% of the world's population. Genetic, physiologic, and epidemiologic studies provide clues to its origins, but a clear understanding has been elusive....

  • Commentary on: The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia. Nasri, Hamid // Journal of Research in Medical Sciences;May2013, Vol. 18 Issue 5, p457 

    A letter to the editor in response to the article "The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia", by M. Jalalzadeh and others, that was published in a 2012 issue of the journal, is presented.

  • Uric Acid and the Developmental Origins of Hypertension. Bonamy, Anna-Karin E. // American Journal of Hypertension;Apr2009, Vol. 22 Issue 4, p349 

    The article reviews the study on the potential mechanism underlying the association between low birth weight and later hypertension in the U.S. The study found that uric acid levels were higher in children born preterm, particularly in those who had higher weight gain from birth three years of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics